Researchers explore whether gut microbes cause some COVID-19 patients to have higher blood clot risk
Medical Xpress - Cardiology
FEBRUARY 23, 2024
A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis—the formation of blood clots—researchers report February 23 in the journal Cell Metabolism. The results also revealed that 2MBC is accumulated in individuals with COVID-19, potentially explaining why these patients are at increased risk of thrombosis.
Let's personalize your content